nChroma Bio
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2024
- Business Model
- B2B
- Website
- nchromabio.com
- Total Funding
- $335.0M
- Last Round
- $75.0M Corporate RoundDec 2024
About
Genetic medicines company developing targeted in vivo delivery and engineered epigenetic silencers for durable treatments, initially focused on liver diseases.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account